Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice

Japanese Journal of Pharmacology

Volumn 76, Issue 2, 1998, Pages 175-183

  Hiroi, Jun ^a   Sengoku, Takanori ^a   Morita, Kyoko ^a   Kishi, Shinichi ^a   Sato, Sachio ^a   Ogawa, Toshikazu ^a   Tsudzuki, Masaoki ^b   Matsuda, Hiroshi ^c   Wada, Adumi ^d   Esaki, Kozaburo ^d  

^a ASTELLAS PHARMA INC   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d Osaka Prefecture University   (Japan)

Author keywords

Atopic dermatitis; FK506; Interleukin 4; Mast cell; T cell

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE VALERATE; CD4 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 4; INTERLEUKIN 5; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DERMATITIS; EOSINOPHIL; FEMALE; HELPER CELL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MAST CELL; MOUSE; NONHUMAN; TOPICAL DRUG ADMINISTRATION;

EID: 0031935041     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.175     Document Type: Article

References (25)

1. Kondo K, Nagami T and Teramoto S: Differences in hematopoietic death among inbred strains of mice. In Comparative Cellular and Species Radiosensitivity, Edited by Bondo PV and Sugahara T, pp 20-29, Igakushoin, Tokyo (1969)
2. Koizumi T and Hayakawa J: The role of immunity on the development of the dermatitis in NC mice. Exp Anim 35, 159-163 (1986) (Abstr in English)
3. Tanioka Y and Esaki K: Strain differences in mortality of anaphylactic shock in mice -Challenging by intravenous injection-. Exp Anim 20, 127-130 (1971) (Abstr in English)
4. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW and Ra C: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9, 461-466 (1977)
5. Tsudzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J and Matsuda H: Genetic analyses for the dermatitis and IgE hyperproduction in the NC/Nga mice. Immunogenetics 47, 88-90 (1997)
6. Cooper KD: Atopic dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 102, 128-137 (1994)
7. Kapp A: Atopic dermatitis-the skin manifestation of atopy. Clin Exp Allergy 25, 210-219 (1995)
8. Kino T, Hatanaka H, Hasimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H and Imanaka H: FK-506, a novel immnosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 40, 1249-1255 (1987)
9. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H and Ochiai T: FK-506, a novel immnosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40, 1256-1265 (1987)
10. Andersson J, Nagy S, Groth C-G and Andersson U: Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a singie-cell level. Immunology 75, 136-142 (1992)
11. Wang SC, Morel PA, Wang Q, Jordan ML, Simmons RL and Tweardy DJ: A dual mechanism of immunosuppressin by FK-506. Transplantation 56, 978-985 (1993)
12. de Paulis A, Cirillo R, Ciccarelli A, de Crescenzo G, Oriente A and Marone G: Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol 147, 4278-4285 (1991)
13. de Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A and Marone G: Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 99, 723-728 (1992)
14. Meingassner JG and Stütz A: Anti-inflammatory effects of macrophilin-interacting drugs in animal models of irritant and allergic contact dermatitis. Int Arch Allergy Immunol 99, 486-489 (1992)
15. Lauerma A, Maibach HI, Granlund H, Erkko P, Kartamaa M and Stubb S: Inhibition contact allergy reactions by topical FK506. Lancet 340, 556 (1992)
16. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H and Harada S: Tacrolims ointment for atopic dermatitis. Lancet 344, 883 (1994)
17. Watanabe N, Kobayashi A, Miyajima H, Hirano T and Ovary Z: Detection of IgE antibody-forming cells by passive cutaneous anaphylaxis using cell extract from lymphoid organs. J Immunol Methods 96, 41-45 (1987)
18. Tamada Y, Ohashi M, Kobayashi T, Yoshida T and Kondo K: Pathological changes during the generation of erythema and alopecia in NC mice. Allergy 25, 829-836 (1976) (in Japanese)
19. Kühn R, Rajewsky K and Müller W: Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710 (1991)
20. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J Exp Med 179, 1367-1371 (1994)
21. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK and Holgate ST: Interleukin 4 is localized to and released by human mast cells. J Exp Med 176, 1381-1386 (1992)
22. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ and Dorf ME: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170, 245-257 (1989)
23. Nakamura M, Odaguchi K, Miyata K, Hirose K, Jyoyama H, Asanuma F, Muraoka Y, Hasegawa T and Tanaka A: Local anti-inflammatory and systemic effect of alclometasone dipropionate. Ōyō Yakuri (Pharmacometrics) 32, 715-732 (1986) (Abstr in English)
24. Kawashima M: Study on the skin atrophy, redness and telangiectasia by 0.05% betamethasone butyrate propionate (TO-186) ointment. Rinshyo Iyaku (J Clin Ther Med) 6, 1683-1692 (1990) (Abstr in English)
25. Hisatomi A, Mitamura T, Kimura M, Oishi Y, Fujii T and Ohara K: Comparison of FK506 (tacrolimus) and glucocorticoid ointment on dermal atrophogenicity in rats. J Toxicol Pathol 10, 97-102 (1997)